Stockreport

Innate Pharma reports FY results [Seeking Alpha]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF Innate Pharma (NASDAQ: IPHA Revenue of €85.81M (-8.6% Y/Y) Press Release [Read more]